https://www.selleckchem.com/pr....oducts/Sorafenib-Tos
Smoking (OR 3.505; p = 0.028), non-steroidal anti-inflammatory drugs intake (OR 3.473; p = 0.021) and small intestine bacterial overgrowth (OR 3.172; p = 0.013) were independent risk factors for altered fecal calprotectin in the absence of endoscopic lesions. No association was found for any of the other variables. CONCLUSIONS smoking and the use of non-steroidal anti-inflammatory drugs are strongly associated with elevated levels of fecal calprotectin in symptomatic patients with a negative colonoscopy and capsule endoscopy
Like
Comment
Share
